136 related articles for article (PubMed ID: 37231874)
1. Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review.
Ali Hailan YM; Al-Dubai HN; Yassin MA
Oncology; 2023; 101(6):362-368. PubMed ID: 37231874
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
Shimon I; Kneller A; Olchovsky D
Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
Wang KL; Lin LY; Chen PM; Lin HD
J Chin Med Assoc; 2005 May; 68(5):230-3. PubMed ID: 15909729
[TBL] [Abstract][Full Text] [Related]
4. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
Pavithran K; Doval DC
Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
6. Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.
Oluwasanjo A; Pathak R; Ukaigwe A; Alese O
Cancer Causes Control; 2016 Jan; 27(1):143-6. PubMed ID: 26453198
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloid leukemia following radioiodine treatment for papillary carcinoma of thyroid.
Gupta G; Aggarwal M; Juneja R; Seth T
Indian J Cancer; 2022; 59(3):436-437. PubMed ID: 36412321
[No Abstract] [Full Text] [Related]
8. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.
Molenaar RJ; Sidana S; Radivoyevitch T; Advani AS; Gerds AT; Carraway HE; Angelini D; Kalaycio M; Nazha A; Adelstein DJ; Nasr C; Maciejewski JP; Majhail NS; Sekeres MA; Mukherjee S
J Clin Oncol; 2018 Jun; 36(18):1831-1839. PubMed ID: 29252123
[TBL] [Abstract][Full Text] [Related]
9. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
Corrêa NL; de Sá LV; de Mello RC
Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
[TBL] [Abstract][Full Text] [Related]
10. Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up.
Barbesino G; Goldfarb M; Parangi S; Yang J; Ross DS; Daniels GH
Thyroid; 2012 Apr; 22(4):369-76. PubMed ID: 22385290
[TBL] [Abstract][Full Text] [Related]
11. Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine.
Jaber T; Waguespack SG; Cabanillas ME; Elbanan M; Vu T; Dadu R; Sherman SI; Amit M; Santos EB; Zafereo M; Busaidy NL
J Clin Endocrinol Metab; 2018 Oct; 103(10):3698-3705. PubMed ID: 30032208
[TBL] [Abstract][Full Text] [Related]
12. Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine.
Alfiar F; Amato D; Lipton JH
Leuk Lymphoma; 1997 Oct; 27(3-4):365-7. PubMed ID: 9402335
[TBL] [Abstract][Full Text] [Related]
13. Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma.
Alsaud A; Mohamed S; Yassin MA; Ashour A; Obeidat K; Azrieh B
Case Rep Oncol; 2020; 13(1):207-211. PubMed ID: 32336971
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Report of a case and review of the literature.
Walgraeve D; Verhoef G; Stul M; Cassiman JJ; Mecucci C; Van den Berghe H; Boogaerts M
Cancer Genet Cytogenet; 1991 Sep; 55(2):217-24. PubMed ID: 1933823
[TBL] [Abstract][Full Text] [Related]
15. Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer.
McCowen KD; Adler RA; Ghaed N; Verdon T; Hofeldt FD
Am J Med; 1976 Jul; 61(1):52-8. PubMed ID: 937370
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
[No Abstract] [Full Text] [Related]
17. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
18. A case of chronic myelogenous leukemia following I131 therapy for metastatic thyroid carcinoma.
Torng JK; Chen YC; Liu CH; Chen FW
Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):730-5. PubMed ID: 6594437
[No Abstract] [Full Text] [Related]
19. Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma.
Kruijff S; Aniss AM; Chen P; Sidhu SB; Delbridge LW; Robinson B; Clifton-Bligh RJ; Roach P; Gill AJ; Learoyd D; Sywak MS
Surgery; 2013 Dec; 154(6):1337-44; discussion 1344-5. PubMed ID: 24383104
[TBL] [Abstract][Full Text] [Related]
20. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
Sacks W; Wong RM; Bresee C; Braunstein GD
Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
